Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Safeguarding human tissue transplants.

J Henkel

    FDA Consumer
    |September 1, 1994
    PubMed
    Summary
    This summary is machine-generated.

    Human tissue transplants, like cornea and bone, offer significant benefits but risk disease transmission. The Food and Drug Administration (FDA) is enhancing safety regulations for transplanted tissues to mitigate these risks.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    [Airway management in children : What should be known in pediatric anesthesia].

    Die Anaesthesiologie·2025
    Same author

    Dynamic changes in macrophage populations and resulting alterations in Prostaglandin E<sub>2</sub> sensitivity in mice with diet-induced MASH.

    Cell communication and signaling : CCS·2025
    Same author

    Characterisation and evaluation of the regenerative capacity of Stro-4+ enriched bone marrow mesenchymal stromal cells using bovine extracellular matrix hydrogel and a novel biocompatible melt electro-written medical-grade polycaprolactone scaffold.

    Biomaterials·2020
    Same author

    A deletion spanning the promoter and first exon of the hair cycle-specific ASIP transcript isoform in black and tan rabbits.

    Animal genetics·2019
    Same author

    A novel KIT deletion variant in a German Riding Pony with white-spotting coat colour phenotype.

    Animal genetics·2019
    Same author

    Whole-genome sequencing reveals a large deletion in the MITF gene in horses with white spotted coat colour and increased risk of deafness.

    Animal genetics·2019
    See all related articles

    Area of Science:

    • Medical science
    • Public health
    • Regulatory affairs

    Background:

    • Human tissue transplantation, including cornea and bone, provides critical medical solutions.
    • A significant risk associated with tissue transplantation is the potential transmission of infectious diseases, such as Human Immunodeficiency Virus (HIV) and hepatitis.
    • Ensuring the safety of transplanted tissues is paramount for patient well-being and public health.

    Purpose of the Study:

    • To inform about the risks associated with human tissue transplantation.
    • To detail the regulatory actions taken by the Food and Drug Administration (FDA) to enhance the safety of transplanted tissues.
    • To indicate ongoing considerations for further regulatory measures.

    Main Methods:

    • Review of current practices and risks in human tissue transplantation.

    Related Experiment Videos

  • Analysis of FDA's regulatory actions and policy changes.
  • Identification of potential future regulatory strategies.

    • Main Results:

    • Transplanted human tissues, while beneficial, carry inherent risks of disease transmission.
    • The FDA has implemented stricter controls on the procurement and processing of transplanted tissues.
    • The FDA is actively evaluating additional measures to further minimize risks.

    Conclusions:

    • Stricter FDA regulations are necessary to ensure the safety of human tissue transplants.
    • Ongoing vigilance and adaptive regulatory strategies are crucial to manage the risks of infectious disease transmission.
    • Balancing the benefits of tissue transplantation with safety concerns remains a key public health challenge.